Asia Healthcare Industry Digest
SEE OTHER BRANDS

The latest healthcare and wellness news from Asia and the Pacific

Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on June 6, 2025

PathFree Technologies Engages Investment Banking Firm to Accelerate Growth, Reflecting Founder’s Grit-Fueled Vision

PathFree Technologies Engages Investment Banking Firm to Accelerate Growth, Reflecting Founder’s Grit-Fueled Vision

Fueled by purpose and perseverance, PathFree Technologies brings life-saving AI to cardiac emergency care. IRVINE, CA, UNITED STATES, June 6, 2025 /⁨EINPresswire.com⁩/ -- PathFree Technologies, an emerging leader in AI-driven emergency medical solutions, …

Antelope Surgical Solutions to Present at BIO International Convention 2025

Antelope Surgical Solutions to Present at BIO International Convention 2025

BIO 2025 presentation to spotlight Antelope’s FDA IND-cleared fluorescent radioligand platform with built-in PET and radiotherapy pivot. NEW YORK, NY, UNITED STATES, June 6, 2025 /⁨EINPresswire.com⁩/ -- Antelope Surgical Solutions, a clinical-stage …

Global Autoinjectors Market Set For 22.0% Growth, Reaching $10.07 Billion By 2029

Global Autoinjectors Market Set For 22.0% Growth, Reaching $10.07 Billion By 2029

The Business Research Company's Global Autoinjectors Market Set For 22.0% Growth, Reaching $10.07 Billion By 2029 LONDON, GREATER LONDON, UNITED KINGDOM, June 6, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s Latest Report Explores Market …

Global Artificial Intelligence Chip Market Set For 41.6% Growth, Reaching $164.07 Billion By 2029

Global Artificial Intelligence Chip Market Set For 41.6% Growth, Reaching $164.07 Billion By 2029

The Business Research Company’s Artificial Intelligence Chip Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 6, 2025 /⁨EINPresswire.com⁩/ -- The artificial intelligence chip market size …

Key Trend Revolutionizing The Arrhythmia Monitoring Devices Market In 2025: Elevating Heart Health With Wearable Devices

Key Trend Revolutionizing The Arrhythmia Monitoring Devices Market In 2025: Elevating Heart Health With Wearable Devices

The Business Research Company’s Arrhythmia Monitoring Devices Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 6, 2025 /⁨EINPresswire.com⁩/ -- According to the latest report from The …

In-Depth Analysis Of The Global Aromatherapy Market: Key Drivers, Trends, Growth Opportunities, And Forecast 2025-2034

In-Depth Analysis Of The Global Aromatherapy Market: Key Drivers, Trends, Growth Opportunities, And Forecast 2025-2034

The Business Research Company’s Aromatherapy Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 6, 2025 /⁨EINPresswire.com⁩/ -- The "Aromatherapy Global Market Report 2025" features vital …

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today …

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, June 06, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …

Rakovina Therapeutics Announces the Closing of Oversubscribed Private Placement of $4.9 Million

Rakovina Therapeutics Announces the Closing of Oversubscribed Private Placement of $4.9 Million

VANCOUVER, British Columbia, June 06, 2025 (GLOBE NEWSWIRE) --  Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered …

RESTEM to Present Phase 2/3 IIMPACT Trial Design in Idiopathic Inflammatory Myopathy at EULAR 2025 Congress

RESTEM to Present Phase 2/3 IIMPACT Trial Design in Idiopathic Inflammatory Myopathy at EULAR 2025 Congress

MIAMI, June 06, 2025 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced that it will present the rationale and study design …

PolyPid to Host Conference Call and Webcast to Discuss D-PLEX₁₀₀ SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025

PolyPid to Host Conference Call and Webcast to Discuss D-PLEX₁₀₀ SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025

PETACH TIKVA, Israel, June 06, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will host a conference call and webcast to report …

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing …

Enovis to Participate in Upcoming Investor Conferences

Enovis to Participate in Upcoming Investor Conferences

Wilmington, DE, June 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences: Goldman Sachs 46th …

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WOBURN, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to newly …

First Ascent Biomedical and Fight Colorectal Cancer Announce Groundbreaking Study to Advance Precision Oncology for Colorectal Cancer Patients

First Ascent Biomedical and Fight Colorectal Cancer Announce Groundbreaking Study to Advance Precision Oncology for Colorectal Cancer Patients

Springfield, Mo., June 06, 2025 (GLOBE NEWSWIRE) -- First Ascent Biomedical (FA), an innovative biotech company specializing in transforming cancer treatment through functional precision medicine, is proud to announce a new collaboration with national …

American Botanical Council Acquires Full Rights to Steven Foster Photo Library

American Botanical Council Acquires Full Rights to Steven Foster Photo Library

Austin, Texas, June 06, 2025 (GLOBE NEWSWIRE) -- The nonprofit American Botanical Council (ABC) announces that it has obtained ownership rights to the entire collection of medicinal and aromatic plant photographs taken by the late botanist, author, and …

Amazing Sesame Introduces Black Sesame Sauce: A Bold New Staple for the Modern Table

Amazing Sesame Introduces Black Sesame Sauce: A Bold New Staple for the Modern Table

Amazing Sesame introduces a rich, velvety sauce that transforms everyday dishes into gourmet experiences. LAOS, LAOS, June 6, 2025 /⁨EINPresswire.com⁩/ -- Amazing Sesame, the brand known for reimagining Asian culinary staples through a modern lens, …

Aventis Graduate School’s Counselling & Psychotherapy Masters Earns Singapore Association for Counselling Accreditation

Aventis Graduate School’s Counselling & Psychotherapy Masters Earns Singapore Association for Counselling Accreditation

Aventis Singapore's MA in Counselling …

Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032

Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032

FLORHAM PARK, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT) today announced that the U.S. Food and Drug Administration (FDA) has approved Phathom’s Citizen Petition filed on December 11, 2024 and communicated the …

Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES

Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES

SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 6 June 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service